Lv1
58 积分 2021-10-26 加入
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life
15小时前
待确认
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
19天前
已完结
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma
1个月前
已完结
Abstract 3228: Characterization of multi-organ system involvement of immune-related adverse events after anti-PD-(L)1 monotherapies: A pooled analysis of clinical trial data submitted to FDA
1个月前
已完结
How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysis
1个月前
已完结
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
1个月前
已完结
Genomic characterization reveals distinct mutational landscape of acral melanoma in East Asian
2个月前
已完结
Examining real world efficacy and toxicity of adjuvant targeted therapy in old vs younger patients with stage III melanoma
2个月前
已关闭
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis
2个月前
已完结
Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma
2个月前
已完结
皖公网安备34019202002308
